Yersinia enterocolitica infection in breeding colonies of ruffed lemurs.
Two outbreaks of yersiniosis caused by Yersinia enterocolitica occurred in breeding colonies of red ruffed lemurs (Varecia variegata rubra) and black and white ruffed lemurs (Varecia variegata variegata) housed in outdoor enclosures during the winter breeding season and spring birth season, respectively. Seven of 11 animals at risk in the combined outbreaks became ill, and 3 died of acute to chronic infection. Clinical signs included anorexia, lethargy, diarrhea, abdominal pain, and hyperpyrexia. Necropsy findings included ulcerative enterocolitis and multifocal necrosis and abscess formation in mesenteric lymph nodes, liver, spleen, kidneys, and lungs. Histologically, lesions were characterized by necrotizing inflammation containing masses of basophilic bacteria. Yersinia enterocolitica serotype 0:2 was isolated from lesions. Neomycin sulfate given orally and chloramphenicol given intramuscularly were effective in treatment early in the course of the disease or in mild cases. In severe cases, lemurs did not respond to antibiotic and fluid therapy. Exposure to soil contaminated with infected rodent feces, stress, and behavioral factors in the ruffed lemur species are believed to have precipitated the infection.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001522:Behavior, Animal; D004196:Disease Outbreaks / Q000662:veterinary*; D005260:Female; D005440:Fluid Therapy; D007900:Lemur; D007901:Lemuridae; D008297:Male; D009657:North Carolina; D013312:Stress, Physiological / Q000662:veterinary; D015009:Yersinia Infections / Q000453:epidemiology / Q000209:etiology / Q000628:therapy / Q000662:veterinary*; D015008:Yersinia enterocolitica
D000900:Anti-Bacterial Agents